Automating Individualized Notification of Drug Recalls to Patients: Complex Challenges and Qualitative Evaluation
Abstract BackgroundConsumer-level drug recalls usually require action by individual patients. The Food and Drug Administration (FDA) has public-facing outlets to inform the public about drug safety information, including all recalls, but individual consumers may not be aware o...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
JMIR Publications
2026-01-01
|
| Ráidu: | JMIRx Med |
| Liŋkkat: | https://xmed.jmir.org/2026/1/e68345 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
